Results 251 to 260 of about 9,606,287 (373)

Identification of wheelchair seating criteria in adults with neuromuscular diseases: A Delphi study

, 2023
Élise Dupitier, M. Voisin, Caroline Stalens, Pascal Laforêt, Samuel Pouplin   +4 more
openalex   +2 more sources

Respiratory Care in Neuromuscular Diseases

Respiratory care, 2018
A. Sahni, L. Wolfe
semanticscholar   +1 more source

The most bothersome symptoms in neuromuscular diseases: the ERN EURO NMD Survey. [PDF]

Orphanet J Rare Dis
Mancuso M, Colitta A, Lavorato M, Van den Bergh P, Kirschner J, Kornblum C, Maggi L, Lamy F, Lochmüller H, Nordstrøm M, Malfatti E, Ferlini A, Pareyson D, Silani V, Kleopa KA, de Visser M, Atalaia A, Evangelista T.   +17 more
europepmc   +1 more source

Atypical Visually Guided Precision Grip Control in Middle‐Aged and Older Autistic Adults

Autism Research, EarlyView.
ABSTRACT Sensorimotor impairments are well documented in autism spectrum disorder (ASD). However, little is known about how these difficulties present in middle‐aged and older autistic adults or how they relate to demographic factors and autistic traits.
Zheng Wang, Hang Qu, Danielle Christensen, Hanna M. Gemmell, Ellen M. Parks, Kyla E. Wetherington, Ann‐Marie Orlando, Regilda A. Romero, Bikram Karmakar, David E. Vaillancourt   +9 more
wiley   +1 more source

Assessing the socio-economic burden of inherited and inflammatory neuromuscular diseases (BIND study): a study protocol. [PDF]

Orphanet J Rare Dis
Smith IC, Abusetah Y, Osman H, Garg A, Grant A, Lochmuller H, McMillan H, Pfeffer G, Korngut L, Gagnon C, Lintern S, Wojtal D, Selby K, Thavorn K, Warman-Chardon J.   +14 more
europepmc   +1 more source

A Clinician's View of Neuromuscular Diseases [PDF]

, 1978
V. Dubowitz
openalex   +1 more source

Switching disease‐modifying therapies in patients with spinal muscular atrophy: A systematic review on effectiveness outcomes

British Journal of Clinical Pharmacology, EarlyView.
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić, Elvira Meni Maria Gkrinia, Patrick Eustaquio, Andrea Katrin Faour, Dinko Vitezić   +4 more
wiley   +1 more source

Neuromuscular diseases: genomics-driven advances. [PDF]

Genomics Inform
Cho A.
europepmc   +1 more source

Review for "Synergistic PXT3003 therapy uncouples neuromuscular function from dysmyelination in male Charcot-Marie-Tooth disease type 1A (CMT1A) rats"

, 2020
Katherine Halievski
openalex   +1 more source

Nonsustained ventricular tachycardia does not affect the prognosis of neuromuscular diseases: A preliminary and retrospective study [PDF]

, 2018
Takahiro Kamihara, Fumihiko Yasuma, Toyoaki Murohara   +2 more
openalex   +1 more source